Clinical Characteristics and Outcome of Pediatric Patients with Relapsed or Refractory Hodgkin Lymphoma: Gazi University Pediatric Oncology Experience

Survival is low in recurrent or refractory Hodgkin Lymphoma (HL) patients. The aim of this study is to evaluate the characteristics and outcomes of relapsed or refractory HL patients in our institution. Patients and Methods: A total of 123 patients with newly diagnosed HL were treated between 1990 and 2013. We retrospectively evaluated the analysis of 9 pediatric patients who have relapsed or progressed. Results: The median age of the patients with recurrent or refractory disease was 12.8 ± 3.4 years (range: 7.5 – 17 years) at the time of initial presentation. The median follow-up of the patients was 68.6 months…